Clinical Trial Update: Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating precision T cells targeting multiple tumor-associated antigens in combination with transarterial chemoembolization for adv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Tumor antigen–specific T cell therapy

Snippet

Sponsor: Second Military Medical University | Conditions: Recurrence Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN